Nasdaq: LYCA · Listed Oct 23, 2026
Lycia Therapeutics IPO
$31.35
▲ +1.39%today · +74.17% since the $18.00 IPO price
15-minute delayed · as of 7:30:02 PM EST on Nov 18, 2026
Lycia Therapeutics (LYCA) priced its IPO at $18.00 a share and has traded on Nasdaq since Oct 23, 2026.
Last session · Nov 18, 2026
- Market cap
- $1.63B
- from the ticker reference
- Volume
- 350.73K
- shares, regular session
- VWAP
- $31.30
- the last price is +0.15% from the volume-weighted average
- Day range
- 30.45–32.85
- low to high
The trading numbers are from the last session, Nov 18, 2026.
The debut race
LYCA against other big listings, as the percent change from each stock's own IPO price.
The first 30 trading days. Each point is the last regular-session trade of a day.
The first trading day.
The first trading day.
The IPO scoreboard
LYCA against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.
| IPO | Raised | First trade | Day 1 close | Day 1 close, as a bar | Day 5 | Day 30 |
|---|---|---|---|---|---|---|
| Lycia Therapeutics '26 | $317.52M | +58.61% | +64.22% | +52.56% | Not yet | |
| Figma '25 | $1.22B | +157.58% | +252.42% | +173.64% | +69.64% | |
| Circle '25 | $1.05B | +122.58% | +168.45% | +278.18% | +622.98% | |
| Reddit '24 | $748M | +38.24% | +47.97% | +69.90% | +40.32% | |
| Arm '23 | $5.23B | +10.00% | +23.76% | +3.63% | -3.06% | |
| Klarna '25 | $1.37B | +30.00% | +16.14% | +13.73% | -7.33% | |
| CoreWeave '25 | $1.5B | -2.50% | +0.02% | +34.32% | +28.42% |
Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.
The offering
The Lycia Therapeutics IPO offers 17.64M shares to raise $317.52M, before any underwriters' option.
- Expected price range
- $16 to $18
- IPO price
- $18.00
- Shares offered
- 17.64M
- Money raised
- $317.52M
- Listing date
- Oct 23, 2026
- Exchange
- Nasdaq
- Security
- Ordinary Shares
Money raised, against the largest IPOs
- Alibaba '14$21.77B
- Facebook '12$18.41B
- Rivian '21$11.93B
- Uber '19$8.1B
- Arm '23$5.23B
- Lycia Therapeutics$317.52M
Where LYCA ranks
Lycia Therapeutics's market cap against the largest US-listed companies.
Market cap, against the largest US-listed companies
- AAPL$5.12T
- MSFT$3.77T
- NVDA$3.65T
- GOOGL$3.47T
- AMZN$2.9T
- TSM$1.88T
- AVGO$1.69T
- META$1.58T
- TSLA$1.52T
- BRK.B$1.22T
- LYCA$1.63B
What comes after the IPO
Options, short interest, analyst ratings, and fund holdings are not available on day one. Each starts on its own date. A date marked est. follows usual market practice.
Oct 23, 2026
First trade
Prices, bars, and snapshots
Oct 28, 2026 · est.
Options list
Option chain and open interest
Nov 12, 2026 · est.
First short interest
Short interest and daily short volume
Nov 17, 2026 · est.
Quiet period ends
Analyst ratings and price targets
Feb 14, 2027
First 13F deadline
Which funds hold the stock
Date not set
First earnings
Income statement and ratios
Apr 20, 2027 · est.
Lock-up expires
Insider sales on Form 4
Filings and the company
What Lycia Therapeutics has disclosed to the SEC, and the basic facts about the listing.
8-K filings
Material events that Lycia Therapeutics discloses to the SEC on Form 8-K.
- Charter amendmentOct 26, 2026
On October 26, 2026, Lycia Therapeutics, Inc. (the "Company") filed its Amended and Restated Certificate of Incorporation (the "Charter") with the Secretary of State of the State of Delaware ... in connection with the closing of the initial public offering (the "Offering") of shares of the Company's common stock.
About Lycia Therapeutics
Lycia Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory and allergic diseases.
- Ticker
- LYCA
- Exchange
- Nasdaq
- Market
- stocks
- Type
- CS
- Currency
- USD
- Listed
- Oct 23, 2026
- Security
- Ordinary Shares
Frequently asked questions
What was the Lycia Therapeutics IPO price?
$18.00 a share.
When did Lycia Therapeutics go public?
Lycia Therapeutics listed on Nasdaq on Oct 23, 2026 under the ticker LYCA.
How much did the Lycia Therapeutics IPO raise?
$317.52M, before any underwriters' option.
How did Lycia Therapeutics open on its first day?
LYCA first traded at $28.55, +58.61% from the IPO price of $18.00.
How did LYCA close on its first day?
Its last regular-session trade was $29.56, +64.22% from the IPO price of $18.00.
What was the LYCA first-day trading range?
$22.19 to $36.49 in the regular session.
How many LYCA shares traded on the first day?
2.21M shares in the regular session.
How many shares did Lycia Therapeutics sell in its IPO?
17.64M shares.
What exchange is LYCA listed on?
Lycia Therapeutics lists on Nasdaq under the ticker LYCA.
Are the prices on this page real time?
No. Prices on this page are delayed 15 minutes. The Massive API and MCP server provide the most current data.
Build with Massive
Get the LYCA data behind this page
| What the page shows | Endpoint |
|---|---|
| Offering terms and dates | /vX/reference/ipos |
| Price | /v3/snapshot |
| Chart, VWAP, and the market comparison | /v2/aggs/ticker/LYCA/range/5/minute |
| Market cap | /v3/reference/tickers/LYCA |
| News | /v2/reference/news |
| Filings | /vX/disclosures |
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.